• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞端粒长度较短可预测美国印第安人颈动脉粥样硬化的发生率和进展:强心家族研究。

Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study.

作者信息

Chen Shufeng, Lin Jue, Matsuguchi Tet, Blackburn Elizabeth, Yeh Fawn, Best Lyle G, Devereux Richard B, Lee Elisa T, Howard Barbara V, Roman Mary J, Zhao Jinying

机构信息

Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA;

出版信息

Aging (Albany NY). 2014 May;6(5):414-27. doi: 10.18632/aging.100671.

DOI:10.18632/aging.100671
PMID:24902894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4069268/
Abstract

Short leukocyte telomere length (LTL) has been associated with atherosclerosis in cross-sectional studies, but the prospective relationship between telomere shortening and risk of developing carotid atherosclerosis has not been well-established. This study examines whether LTL at baseline predicts incidence and progression of carotid atherosclerosis in American Indians in the Strong Heart Study. The analysis included 2,819 participants who were free of overt cardiovascular disease at baseline (2001-2003) and were followed through the end of 2006-2009 (average 5.5-yr follow-up). Discrete atherosclerotic plaque was defined as focal protrusion with an arterial wall thickness ≥50% the surrounding wall. Carotid progression was defined as having a higher plaque score at the end of study follow-up compared to baseline. Associations of LTL with incidence and progression of carotid plaque were examined using Cox proportional hazard regression, adjusting for standard coronary risk factors. Compared to participants in the highest LTL tertile, those in the lowest tertile had significantly elevated risk for both incident plaque (HR, 1.49; 95% CI, 1.09-2.03) and plaque progression (HR, 1.61; 95% CI, 1.26-2.07). Our results provide initial evidence for a potential prognostic utility of LTL in risk prediction for atherosclerosis.

摘要

在横断面研究中,短白细胞端粒长度(LTL)与动脉粥样硬化有关,但端粒缩短与颈动脉粥样硬化发生风险之间的前瞻性关系尚未完全确立。本研究在强心研究中调查了美国印第安人基线时的LTL是否能预测颈动脉粥样硬化的发生率和进展情况。分析纳入了2819名在基线时(2001 - 2003年)无明显心血管疾病且随访至2006 - 2009年底(平均随访5.5年)的参与者。离散性动脉粥样硬化斑块定义为动脉壁厚度≥周围管壁50%的局灶性突出。颈动脉进展定义为研究随访结束时的斑块评分高于基线。使用Cox比例风险回归分析LTL与颈动脉斑块发生率和进展的关联,并对标准冠状动脉危险因素进行校正。与LTL最高三分位数的参与者相比,最低三分位数的参与者发生斑块(风险比[HR],1.49;95%置信区间[CI],1.09 - 2.03)和斑块进展(HR,1.61;95% CI,1.26 - 2.07)的风险均显著升高。我们的结果为LTL在动脉粥样硬化风险预测中的潜在预后效用提供了初步证据。

相似文献

1
Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study.白细胞端粒长度较短可预测美国印第安人颈动脉粥样硬化的发生率和进展:强心家族研究。
Aging (Albany NY). 2014 May;6(5):414-27. doi: 10.18632/aging.100671.
2
Plasminogen activator inhibitor-1 is associated with leukocyte telomere length in American Indians: findings from the Strong Heart Family Study.纤溶酶原激活物抑制剂-1与美国印第安人的白细胞端粒长度相关:强心脏家族研究的结果
J Thromb Haemost. 2017 Jun;15(6):1078-1085. doi: 10.1111/jth.13689. Epub 2017 May 3.
3
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study.短端粒负荷、端粒长度与亚临床动脉粥样硬化:PE-SA 研究。
J Am Coll Cardiol. 2016 May 31;67(21):2467-76. doi: 10.1016/j.jacc.2016.03.530.
4
Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study.短白细胞端粒体长度预测美洲印第安人患糖尿病的风险:强心家族研究。
Diabetes. 2014 Jan;63(1):354-62. doi: 10.2337/db13-0744. Epub 2013 Aug 15.
5
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population.端粒缩短超过 6 年与一般人群亚临床颈动脉血管损伤增加和心血管预后恶化相关。
J Intern Med. 2015 Apr;277(4):478-87. doi: 10.1111/joim.12282. Epub 2014 Jul 19.
6
Leukocyte telomere length and cardiovascular disease in African Americans: The Jackson Heart Study.非裔美国人的白细胞端粒长度与心血管疾病:杰克逊心脏研究。
Atherosclerosis. 2017 Nov;266:41-47. doi: 10.1016/j.atherosclerosis.2017.09.016. Epub 2017 Sep 15.
7
Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study.美国印第安人的白细胞端粒长度与理想心血管健康:强心家族研究
Eur J Epidemiol. 2017 Jan;32(1):67-75. doi: 10.1007/s10654-016-0199-6. Epub 2016 Sep 22.
8
Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.血管生物标志物在预测临床心血管疾病中的作用:“强壮心脏研究”。
Hypertension. 2012 Jan;59(1):29-35. doi: 10.1161/HYPERTENSIONAHA.111.181925. Epub 2011 Nov 7.
9
Short leukocyte telomere length is associated with obesity in American Indians: the Strong Heart Family study.白细胞端粒长度较短与美国印第安人的肥胖有关:强心家族研究。
Aging (Albany NY). 2014 May;6(5):380-9. doi: 10.18632/aging.100664.
10
Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study.生物衰老对美国印第安人动脉衰老的影响:强心脏家族研究的结果
Aging (Albany NY). 2016 Aug;8(8):1583-92. doi: 10.18632/aging.101013.

引用本文的文献

1
The Interplay Between Obesity and Type 2 Diabetes: Common Pathophysiological Mechanisms Contributing to Telomere Shortening.肥胖与2型糖尿病之间的相互作用:导致端粒缩短的共同病理生理机制
Life (Basel). 2025 May 28;15(6):873. doi: 10.3390/life15060873.
2
Two Modeling Strategies in Analyzing Clustered Time-to-Event Data: the Strong Heart Family Study.分析聚类事件发生时间数据的两种建模策略:强心家庭研究。
Prev Chronic Dis. 2025 Mar 27;22:E12. doi: 10.5888/pcd22.240387.
3
Telomere length as a biomarker for cerebrovascular diseases: current evidence.端粒长度作为脑血管疾病的生物标志物:当前证据。
Mol Biol Rep. 2024 Nov 13;51(1):1150. doi: 10.1007/s11033-024-10077-8.
4
Dyslipidemia in American Indian Adolescents and Young Adults: Strong Heart Family Study.美国印第安青少年和年轻成年人的血脂异常:强心家族研究。
J Am Heart Assoc. 2024 Mar 19;13(6):e031741. doi: 10.1161/JAHA.123.031741. Epub 2024 Mar 6.
5
Cardiac System during the Aging Process.衰老过程中的心脏系统。
Aging Dis. 2023 Aug 1;14(4):1105-1122. doi: 10.14336/AD.2023.0115.
6
Canonical and extra-telomeric functions of telomerase: Implications for healthy ageing conferred by endurance training.端粒酶的规范和端粒外功能:耐力训练赋予健康衰老的意义。
Aging Cell. 2023 Jun;22(6):e13836. doi: 10.1111/acel.13836. Epub 2023 Apr 11.
7
Remission of insomnia in older adults treated with cognitive behavioral therapy for insomnia (CBT-I) reduces p16 gene expression in peripheral blood: secondary outcome analysis from a randomized clinical trial.认知行为疗法治疗失眠症(CBT-I)可缓解老年人失眠症的缓解:一项随机临床试验的次要结局分析。
Geroscience. 2023 Aug;45(4):2325-2335. doi: 10.1007/s11357-023-00741-5. Epub 2023 Feb 28.
8
Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target.端粒长度:心血管生物标志物和新的治疗靶点。
Int J Mol Sci. 2022 Dec 16;23(24):16010. doi: 10.3390/ijms232416010.
9
A healthy lifestyle is positively associated with mental health and well-being and core markers in ageing.健康的生活方式与心理健康和幸福感以及衰老的核心标志呈正相关。
BMC Med. 2022 Sep 29;20(1):328. doi: 10.1186/s12916-022-02524-9.
10
Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms.血管系统的老化是一个复杂的过程:基石机制。
Int J Mol Sci. 2022 Jun 22;23(13):6926. doi: 10.3390/ijms23136926.

本文引用的文献

1
QTL mapping of leukocyte telomere length in American Indians: the Strong Heart Family Study.美洲印第安人白细胞端粒长度的数量性状基因座定位:强心脏家族研究
Aging (Albany NY). 2013 Sep;5(9):704-16. doi: 10.18632/aging.100600.
2
Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study.短白细胞端粒体长度预测美洲印第安人患糖尿病的风险:强心家族研究。
Diabetes. 2014 Jan;63(1):354-62. doi: 10.2337/db13-0744. Epub 2013 Aug 15.
3
Leukocyte telomere length and coronary artery calcification in Palestinians.巴勒斯坦人白细胞端粒长度与冠状动脉钙化。
Atherosclerosis. 2013 Aug;229(2):363-8. doi: 10.1016/j.atherosclerosis.2013.05.030. Epub 2013 Jun 6.
4
Carotid artery plaque and progression of coronary artery calcium: the multi-ethnic study of atherosclerosis.颈动脉斑块与冠状动脉钙进展:动脉粥样硬化的多民族研究。
J Am Soc Echocardiogr. 2013 May;26(5):548-55. doi: 10.1016/j.echo.2013.02.009. Epub 2013 Mar 21.
5
The roles of senescence and telomere shortening in cardiovascular disease.衰老和端粒缩短在心血管疾病中的作用。
Nat Rev Cardiol. 2013 May;10(5):274-83. doi: 10.1038/nrcardio.2013.30. Epub 2013 Mar 12.
6
Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.衰老与动脉粥样硬化:细胞衰老的机制、功能后果和潜在治疗方法。
Circ Res. 2012 Jul 6;111(2):245-59. doi: 10.1161/CIRCRESAHA.111.261388.
7
Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations.中国内地人群白细胞端粒长度与 2 型糖尿病的关联。
J Clin Endocrinol Metab. 2012 Apr;97(4):1371-4. doi: 10.1210/jc.2011-1562. Epub 2012 Feb 8.
8
Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.血管生物标志物在预测临床心血管疾病中的作用:“强壮心脏研究”。
Hypertension. 2012 Jan;59(1):29-35. doi: 10.1161/HYPERTENSIONAHA.111.181925. Epub 2011 Nov 7.
9
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.美国心脏协会/美国心脏病学会基金会关于冠心病及其他动脉粥样硬化性血管疾病患者的二级预防和风险降低治疗:2011年更新版:由世界心脏联盟和心血管预防护士协会认可的美国心脏协会和美国心脏病学会基金会指南
J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46. doi: 10.1016/j.jacc.2011.10.824. Epub 2011 Nov 3.
10
Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR.Southern 印迹法和 qPCR 测量白细胞端粒长度/DNA 含量的公正比较分析。
Nucleic Acids Res. 2011 Nov 1;39(20):e134. doi: 10.1093/nar/gkr634. Epub 2011 Aug 8.